| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.
|
Blood
|
2010
|
3.03
|
|
2
|
The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells.
|
Biomaterials
|
2007
|
2.16
|
|
3
|
Isolation of multipotent cells from human term placenta.
|
Stem Cells
|
2005
|
2.03
|
|
4
|
Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium.
|
Circ Arrhythm Electrophysiol
|
2012
|
2.01
|
|
5
|
Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling.
|
Nano Lett
|
2007
|
1.91
|
|
6
|
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.
|
Blood
|
2009
|
1.87
|
|
7
|
Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.
|
Stem Cells
|
2006
|
1.63
|
|
8
|
Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis.
|
J Cardiovasc Electrophysiol
|
2011
|
1.60
|
|
9
|
Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes.
|
Crit Care Med
|
2010
|
1.57
|
|
10
|
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations.
|
Blood
|
2010
|
1.57
|
|
11
|
Effects of aging and ouabain on left atrial arrhythmogenicity.
|
J Cardiovasc Electrophysiol
|
2007
|
1.55
|
|
12
|
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
|
Blood
|
2011
|
1.55
|
|
13
|
Survival-weighted health profile for long-term survivors of acute myelogenous leukemia.
|
Qual Life Res
|
2003
|
1.46
|
|
14
|
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.
|
Blood
|
2011
|
1.44
|
|
15
|
Heart failure enhances arrhythmogenesis in pulmonary veins.
|
Clin Exp Pharmacol Physiol
|
2011
|
1.41
|
|
16
|
Heat-stress responses modulate beta-adrenergic agonist and angiotensin II effects on the arrhythmogenesis of pulmonary vein cardiomyocytes.
|
J Cardiovasc Electrophysiol
|
2011
|
1.39
|
|
17
|
Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking.
|
Small
|
2008
|
1.37
|
|
18
|
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking.
|
FASEB J
|
2005
|
1.37
|
|
19
|
Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.
|
Cancer Res
|
2006
|
1.31
|
|
20
|
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
|
Biomaterials
|
2009
|
1.29
|
|
21
|
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system.
|
Blood
|
2010
|
1.24
|
|
22
|
In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells.
|
Stem Cells
|
2006
|
1.22
|
|
23
|
The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells.
|
Toxicol Appl Pharmacol
|
2010
|
1.19
|
|
24
|
Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years.
|
Cancer
|
2007
|
1.19
|
|
25
|
Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma.
|
Cancer
|
2004
|
1.19
|
|
26
|
High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe.
|
Small
|
2008
|
1.15
|
|
27
|
Electrophysiology of single cardiomyocytes isolated from rabbit pulmonary veins: implication in initiation of focal atrial fibrillation.
|
Basic Res Cardiol
|
2002
|
1.14
|
|
28
|
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.
|
Am J Hematol
|
2013
|
1.10
|
|
29
|
Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cells.
|
J Biomech
|
2008
|
1.09
|
|
30
|
Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents.
|
Heart Rhythm
|
2007
|
1.06
|
|
31
|
Calmodulin kinase II inhibition prevents arrhythmic activity induced by alpha and beta adrenergic agonists in rabbit pulmonary veins.
|
Eur J Pharmacol
|
2007
|
1.05
|
|
32
|
Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
|
Small
|
2008
|
1.02
|
|
33
|
Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
|
Histopathology
|
2011
|
1.01
|
|
34
|
Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation.
|
Basic Res Cardiol
|
2012
|
1.00
|
|
35
|
Multilineage differentiation and characterization of the human fetal osteoblastic 1.19 cell line: a possible in vitro model of human mesenchymal progenitors.
|
Stem Cells
|
2007
|
0.99
|
|
36
|
Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
|
J Formos Med Assoc
|
2004
|
0.98
|
|
37
|
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution.
|
Am J Hematol
|
2013
|
0.97
|
|
38
|
Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
|
Am J Hematol
|
2002
|
0.96
|
|
39
|
Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells.
|
Toxicol Appl Pharmacol
|
2008
|
0.95
|
|
40
|
Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs).
|
Cell Transplant
|
2011
|
0.95
|
|
41
|
Electromechanical effects of 1,25-dihydroxyvitamin d with antiatrial fibrillation activities.
|
J Cardiovasc Electrophysiol
|
2013
|
0.93
|
|
42
|
Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity.
|
Cardiovasc Res
|
2006
|
0.93
|
|
43
|
Differential expression of connexin43 gap junctions in cardiomyocytes isolated from canine thoracic veins.
|
J Histochem Cytochem
|
2003
|
0.93
|
|
44
|
Oscillatory transient inward currents in ventricular myocytes of healthy versus myopathic Syrian hamster.
|
Clin Exp Pharmacol Physiol
|
2004
|
0.92
|
|
45
|
Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins.
|
Br J Pharmacol
|
2006
|
0.92
|
|
46
|
Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy.
|
ACS Nano
|
2011
|
0.91
|
|
47
|
Heat shock protein inducer modifies arrhythmogenic substrate and inhibits atrial fibrillation in the failing heart.
|
Int J Cardiol
|
2013
|
0.91
|
|
48
|
Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes.
|
Basic Res Cardiol
|
2010
|
0.90
|
|
49
|
In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.
|
Biomaterials
|
2011
|
0.90
|
|
50
|
SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
|
Genes Chromosomes Cancer
|
2003
|
0.90
|
|
51
|
Sex differences in the electrophysiological characteristics of pulmonary veins and left atrium and their clinical implication in atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.89
|
|
52
|
Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes.
|
Life Sci
|
2007
|
0.89
|
|
53
|
Electrophysiology and arrhythmogenic activity of single cardiomyocytes from canine superior vena cava.
|
Circulation
|
2002
|
0.87
|
|
54
|
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.
|
Ann Hematol
|
2014
|
0.87
|
|
55
|
Changes in ionic currents and reduced conduction velocity in hypertrophied ventricular myocardium of Xin alpha-deficient mice.
|
Anadolu Kardiyol Derg
|
2007
|
0.87
|
|
56
|
Oxidative stress and inflammation modulate peroxisome proliferator-activated receptors with regional discrepancy in diabetic heart.
|
Eur J Clin Invest
|
2010
|
0.87
|
|
57
|
Oxidative stress on pulmonary vein and left atrium arrhythmogenesis.
|
Circ J
|
2010
|
0.86
|
|
58
|
Clinical implications of SOCS1 methylation in myelodysplastic syndrome.
|
Br J Haematol
|
2006
|
0.86
|
|
59
|
FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells.
|
Eur J Clin Invest
|
2014
|
0.85
|
|
60
|
Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells.
|
Free Radic Biol Med
|
2006
|
0.85
|
|
61
|
Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis.
|
Ann Hematol
|
2003
|
0.85
|
|
62
|
Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes.
|
Clin Sci (Lond)
|
2011
|
0.84
|
|
63
|
Rosiglitazone induces arrhythmogenesis in diabetic hypertensive rats with calcium handling alteration.
|
Int J Cardiol
|
2011
|
0.84
|
|
64
|
Electromechanical effects of the direct renin inhibitor (aliskiren) on the pulmonary vein and atrium.
|
Basic Res Cardiol
|
2011
|
0.84
|
|
65
|
Study of the cytochrome b gene sequence in populations of Taiwan.
|
J Forensic Sci
|
2009
|
0.84
|
|
66
|
Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium.
|
Clin Sci (Lond)
|
2012
|
0.84
|
|
67
|
Endothelin-1 modulates the arrhythmogenic activity of pulmonary veins.
|
J Cardiovasc Electrophysiol
|
2008
|
0.83
|
|
68
|
Intercalated disc-associated protein, mXin-alpha, influences surface expression of ITO currents in ventricular myocytes.
|
Front Biosci (Elite Ed)
|
2011
|
0.83
|
|
69
|
Increased Ca(2+) sparks and sarcoplasmic reticulum Ca(2+) stores potentially determine the spontaneous activity of pulmonary vein cardiomyocytes.
|
Life Sci
|
2008
|
0.82
|
|
70
|
Fluvastatin reduces pulmonary vein spontaneous activity through nitric oxide pathway.
|
J Cardiovasc Electrophysiol
|
2008
|
0.82
|
|
71
|
Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro.
|
Tissue Eng Part A
|
2008
|
0.82
|
|
72
|
Nitroprusside modulates pulmonary vein arrhythmogenic activity.
|
J Biomed Sci
|
2010
|
0.82
|
|
73
|
Extracellular matrix of collagen modulates intracellular calcium handling and electrophysiological characteristics of HL-1 cardiomyocytes with activation of angiotensin II type 1 receptor.
|
J Card Fail
|
2010
|
0.82
|
|
74
|
Heart failure enhanced pulmonary vein arrhythmogenesis and dysregulated sodium and calcium homeostasis with increased calcium sparks.
|
J Cardiovasc Electrophysiol
|
2011
|
0.82
|
|
75
|
Heart failure epicardial fat increases atrial arrhythmogenesis.
|
Int J Cardiol
|
2012
|
0.81
|
|
76
|
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
|
Am J Hematol
|
2014
|
0.81
|
|
77
|
Vasodilator action of docosahexaenoic acid (DHA) in human coronary arteries in vitro.
|
Chin J Physiol
|
2007
|
0.81
|
|
78
|
Apamin modulates electrophysiological characteristics of the pulmonary vein and the Sinoatrial Node.
|
Eur J Clin Invest
|
2013
|
0.81
|
|
79
|
Analysis of cases of sexual assault presenting at a medical center in Taipei.
|
Taiwan J Obstet Gynecol
|
2010
|
0.81
|
|
80
|
Eicosapentaenoic acid reduces the pulmonary vein arrhythmias through nitric oxide.
|
Life Sci
|
2011
|
0.81
|
|
81
|
Distinctive electrophysiological characteristics of right ventricular out-flow tract cardiomyocytes.
|
J Cell Mol Med
|
2014
|
0.80
|
|
82
|
Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
|
J Heart Lung Transplant
|
2006
|
0.80
|
|
83
|
Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation.
|
Clin Exp Pharmacol Physiol
|
2013
|
0.80
|
|
84
|
Leptin modulates electrophysiological characteristics and isoproterenol-induced arrhythmogenesis in atrial myocytes.
|
J Biomed Sci
|
2013
|
0.80
|
|
85
|
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.
|
Am J Hematol
|
2014
|
0.80
|
|
86
|
Ablation of the androgen receptor gene modulates atrial electrophysiology and arrhythmogenesis with calcium protein dysregulation.
|
Endocrinology
|
2013
|
0.79
|
|
87
|
Distinctive sodium and calcium regulation associated with sex differences in atrial electrophysiology of rabbits.
|
Int J Cardiol
|
2013
|
0.79
|
|
88
|
Temperature regulates the arrhythmogenic activity of pulmonary vein cardiomyocytes.
|
J Biomed Sci
|
2003
|
0.79
|
|
89
|
The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.
|
J Cardiovasc Electrophysiol
|
2014
|
0.79
|
|
90
|
Extracellular matrix of collagen modulates arrhythmogenic activity of pulmonary veins through p38 MAPK activation.
|
J Mol Cell Cardiol
|
2013
|
0.79
|
|
91
|
ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome.
|
Eur J Clin Invest
|
2012
|
0.78
|
|
92
|
Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells.
|
Nanotechnology
|
2010
|
0.78
|
|
93
|
Amyloid peptide regulates calcium homoeostasis and arrhythmogenesis in pulmonary vein cardiomyocytes.
|
Eur J Clin Invest
|
2011
|
0.78
|
|
94
|
Novobiocin sensitizes BCRP/MXR/ABCP overexpressing topotecan-resistant human breast carcinoma cells to topotecan and mitoxantrone.
|
Anticancer Res
|
2003
|
0.78
|
|
95
|
High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan.
|
J Formos Med Assoc
|
2002
|
0.77
|
|
96
|
Electrophysiological characteristics of complex fractionated electrograms and high frequency activity in atrial fibrillation.
|
Int J Cardiol
|
2013
|
0.77
|
|
97
|
Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes.
|
Lab Invest
|
2011
|
0.77
|
|
98
|
Diverse cell morphology and intracellular calcium dynamics in pulmonary vein cardiomyocytes.
|
Heart Vessels
|
2010
|
0.77
|
|
99
|
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan.
|
J Formos Med Assoc
|
2008
|
0.77
|
|
100
|
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
|
Ann Hematol
|
2014
|
0.76
|
|
101
|
Reduced Ca2+ transport across sarcolemma but enhanced spontaneous activity in cardiomyocytes isolated from left atrium-pulmonary veins tissue of myopathic hamster.
|
J Biomed Sci
|
2009
|
0.75
|
|
102
|
Rivaroxaban modulates electrical and mechanical characteristics of left atrium.
|
J Biomed Sci
|
2013
|
0.75
|
|
103
|
Response to letter regarding article, "Dabigatran and thrombin modulate electrophysiological characteristics of pulmonary vein and left atrium" by Chang et al.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.75
|
|
104
|
Different effects of dronedarone and amiodarone on pulmonary vein electrophysiology, mechanical properties and H2O2-induced arrhythmogenicity.
|
Eur J Pharmacol
|
2013
|
0.75
|
|
105
|
Hypertonicity increases rabbit atrium and pulmonary vein arrhythmogenesis: a potential contributor to the genesis of atrial fibrillation.
|
Clin Exp Pharmacol Physiol
|
2008
|
0.75
|
|
106
|
Effects of cyclopiazonic acid on triggered activities in ventricular muscle and cardiomyocytes isolated from hamster hearts.
|
Chin J Physiol
|
2004
|
0.75
|
|
107
|
HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia.
|
J Formos Med Assoc
|
2009
|
0.75
|
|
108
|
Atherosclerosis modulates the electrophysiological effects of a peroxisome proliferator-activated receptor-gamma activator on pulmonary veins.
|
Int J Cardiol
|
2010
|
0.75
|
|
109
|
Acquisition and cure of autoimmune disease following allogeneic hematopoietic stem cell transplantation.
|
J Formos Med Assoc
|
2007
|
0.75
|
|
110
|
Pathophysiology of the pulmonary vein as an atrial fibrillation initiator.
|
Pacing Clin Electrophysiol
|
2003
|
0.75
|
|
111
|
Cariporide (HOE642) attenuates lactic acidosis induced pulmonary vein arrhythmogenesis.
|
Life Sci
|
2009
|
0.75
|
|
112
|
Effect of External Pressure and Catheter Gauge on Flow Rate, Kinetic Energy, and Endothelial Injury During Intravenous Fluid Administration in a Rabbit Model.
|
Shock
|
2016
|
0.75
|
|
113
|
Anaplastic large cell lymphoma in leukemic transformation: successful treatment by transplantation.
|
J Clin Oncol
|
2007
|
0.75
|
|
114
|
Heterogeneity of propagation of excitation in epicardium of pulmonary veins ostia in rabbit during cooling.
|
Anadolu Kardiyol Derg
|
2007
|
0.75
|
|
115
|
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma.
|
Ann Hematol
|
2003
|
0.75
|
|
116
|
A new system for forensic physicians in Taiwan.
|
Leg Med (Tokyo)
|
2009
|
0.75
|
|
117
|
Mononucleated and binucleated cardiomyocytes in left atrium and pulmonary vein have different electrical activity and calcium dynamics.
|
Prog Biophys Mol Biol
|
2011
|
0.75
|
|
118
|
Apelin regulates the electrophysiological characteristics of atrial myocytes.
|
Eur J Clin Invest
|
2012
|
0.75
|